MedTrace Logo

Pelvic and Hip Morphometry in Piriformis Syndrome

NCT04600024 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2020-10-23

No results posted yet for this study

Summary

In this case-control study, 23 patients diagnosed as PS by diagnostic injection with ultrasound guidance were selected as the study group. 22 patients who were excluded from the diagnosis of PS and had anteroposterior (AP) direct radiographic imaging were evaluated as the control group. On the AP Pelvic graph, the femoral neck-shaft angle, the distances between predetermined bony landmarks were measured blindly without knowing the diagnosis, and the findings were compared statistically.

This study aims to evaluate whether the anatomical structure of the pelvis predisposes to the etiopathogenesis of the piriformis syndrome.

Conditions

  • Piriformis Muscle Syndrome
  • Anthropometry

Interventions

DIAGNOSTIC_TEST

Ultrasound guided diagnostic injection

4 cc lidocaine %2 injection into the piriformis muscle was performed for the diagnosis of piriformis syndrome. It was performed by the ultrasound-guidance to increase the accuracy of the injection.

Sponsors & Collaborators

  • Fatih Sultan Mehmet Training and Research Hospital

    lead OTHER

Principal Investigators

  • Gamze Güleç, MD · Fatih Sultan Mehmet Training and Research Hospital

  • Ilknur Aktas, MD · Fatih Sultan Mehmet Training and Research Hospital

  • Feyza Unlu Ozkan, MD · Fatih Sultan Mehmet Training and Research Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-20
Primary Completion
2020-03-18
Completion
2020-06-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04600024 on ClinicalTrials.gov